• Issue

    Clinical and Experimental Neuroimmunology: Volume 16, Issue 2

    85-187
    May 2025
Previous Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 85-87
  • First Published: 08 May 2025

MUSCLE DISEASE

ORIGINAL ARTICLE

Open Access

Development of an immunoprecipitation assay for detecting anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies using a non-radioactive biotinylated recombinant protein

Yukihiro Nishikawa,  Kimiko Hasegawa,  Hiroki Abe,  Shun Matsuzawa,  Takuya Isayama,  Ran Nakashima,  Yoshihiko Saito,  Ichizo Nishino,  Masataka Kuwana, 
  • Pages: 88-97
  • First Published: 18 August 2024
Development of an immunoprecipitation assay for detecting anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies using a non-radioactive biotinylated recombinant protein

Principle and performance of an immunoprecipitation assay for detecting anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) autoantibodies using a non-radioactive biotinylated recombinant protein. This new assay can serve as a potential alternative to the gold standard immunoprecipitation assay for detecting anti-anti-3-hydroxy-3-methylglutaryl-coenzyme A autoantibodies.

GBS/CIDP AND ALLIED DISORDERS

ORIGINAL ARTICLE

Open Access

Diagnostic testing and treatment in Japanese patients with a diagnosis code for chronic inflammatory demyelinating polyradiculoneuropathy: A claims database analysis

Motoi Kuwahara,  Susumu Kusunoki,  Ataru Igarashi,  Satoshi Akiyama,  Taku Fukushima,  Mamoru Doi, 
  • Pages: 98-107
  • First Published: 18 September 2024
Open Access

Real-world safety and treatment patterns of subcutaneous IgPro20 for chronic inflammatory demyelinating polyneuropathy: Post-marketing surveillance in Japan

Naoki Terasaka,  Takanori Mizushima,  Yuki Niwa,  Tetsushi Akasaki,  Hideo Usui, 
  • Pages: 108-117
  • First Published: 03 October 2024

MS/NMO AND ALLIED DISORDERS

ORIGINAL ARTICLE

Open Access

Safety and effectiveness of fingolimod in Japanese patients with multiple sclerosis: Results of a post-marketing surveillance study

Noriko Sato,  Koji Wakimoto,  Kyoko Kato,  Yutaka Susuta,  Kengo Ueda,  Yoshihisa Satou,  Takayoshi Sasajima,  Jun-ichi Kira, 
  • Pages: 118-131
  • First Published: 19 September 2024

IMMUNOLOGY AND OTHER INFLAMMATORY DISORDERS

CLINICAL LETTER

Paraneoplastic stiff-leg syndrome: Positive anti-amphiphysin antibodies associated with breast cancer

Andreia Ferreira,  Cristina Cruz,  Marta Almeida,  Joana Pinto,  Sofia Rocha, 
  • Pages: 132-134
  • First Published: 19 August 2024

REVIEW ARTICLE

Immunocellular microenvironment of the vascular wall of cerebral aneurysms: What is the role of inflammatory cells in aneurysmal remodeling?

Vivig Shantha Kumar,  Nerella Resheek,  Vignarth Shantha Kumar,  Ruthvik Thaghalli Sunil Kumar, 
  • Pages: 135-147
  • First Published: 08 September 2024

FOCUSED REVIEW SERIES THEME: UNVEILING THE MYSTERIES OF RARE NEUROIMMUNOLOGICAL DISORDERS

EDITORIAL

Unveiling the Mysteries of Rare Neuroimmunological Disorders

Yoshihisa Yamano, 
  • Page: 148
  • First Published: 13 April 2025

INVITED REVIEW

Human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis and multiple sclerosis: Viral strategies and their implications

Makoto Nakashima,  Yoshihisa Yamano, 
  • Pages: 149-160
  • First Published: 06 February 2025

Autoimmune cerebellar ataxia: An overlooked, but treatable, neuroimmune condition

Hiroaki Yaguchi,  Akihiko Kudo,  Ichiro Yabe, 
  • Pages: 161-173
  • First Published: 16 March 2025
Open Access

Clinical and Radiological Advances in Autoimmune GFAP Astrocytopathy: Analysis of 387 Patients in Japan

Akio Kimura, 
  • Pages: 174-187
  • First Published: 17 April 2025